No Data
Private Companies Are Fujian Wanchen Biotechnology Group Co., Ltd.'s (SZSE:300972) Biggest Owners and Were Rewarded After Market Cap Rose by CN¥514m Last Week
Fujian Wanchen Biotechnology Group: Half-year report for the year 2024.
Fujian Wanchen Biotechnology Group: Summary of Half-Year Report in 2024.
Wanchen Group: The number of bulk snack stores exceeded 6,600 in Q2, with a slight increase in net margin compared to the previous quarter. Interpreting the financial report.
1. In the first half of the year, the company's revenue increased by 392.45% year-on-year, with revenue of 10.674 billion yuan from the snack retail business, a year-on-year increase of 447.78%; 2.During the reporting period, the company's "Want Want" brand snack stores increased by a net of 1912 stores, resulting in a total of 6638 stores at the end of the period; 3. Along with the expansion of the snack retail business, the company incurred sales expenses of 0.491 billion yuan in the first half of the year, a year-on-year increase of 331.82%.
Wanchen Group (300972.SZ): The net income in the first half of the year was 0.9346 million yuan, turning losses around year-on-year.
On August 16th, Gelunhui reported that Wanchen Group (300972.SZ) had released its 2024 interim report, with a revenue of 10.915 billion yuan, a year-on-year increase of 392.45%, and a net profit attributable to shareholders of the listed company of 0.9346 million yuan, which turned from a loss to a profit year-on-year. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was -3.0812 million yuan. The basic EPS was 0.0057 yuan.
Wanchen Group (300972.SZ) granted 0.77 million shares of Class II restricted stocks at a grant price of 15.17 yuan/share.
Wanchen Group (300972.SZ) has issued an announcement regarding the 2024 third interim shareholders' meeting resolutions ...
Potential Upside For Fujian Wanchen Biotechnology Group Co., Ltd. (SZSE:300972) Not Without RiskNo Data
No Data
